Ali Hamit, Begum Ozturk Nazli, Herdan N Emre, Luu Harry, Simsek Cem, Kazancioglu Rumeyza, Gurakar Ahmet
Division of Gastroenterology & Hepatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Internal Medicine, Beaumont Hospital, Royal Oak, Michigan, USA.
Hepatol Forum. 2024 Mar 22;5(4):207-210. doi: 10.14744/hf.2023.2023.0071. eCollection 2024.
Simultaneous liver-kidney transplantation (SLK) is a feasible option for patients with end-stage liver disease and concomitant renal dysfunction or end-stage renal disease. SLK has gained significant attention primarily due to multiple alterations in the allocation criteria over the past two decades. This review aims to summarize the most recent updates and outcomes of the SLK allocation policy, comparing SLK outcomes with those of liver transplantation alone and exploring the implications of donation after cardiac death in SLK procedures.
肝肾联合移植(SLK)对于患有终末期肝病并伴有肾功能不全或终末期肾病的患者来说是一种可行的选择。主要由于在过去二十年中分配标准的多次变更,肝肾联合移植已受到广泛关注。本综述旨在总结肝肾联合移植分配政策的最新进展和结果,将肝肾联合移植的结果与单纯肝移植的结果进行比较,并探讨心脏死亡后捐赠在肝肾联合移植手术中的意义。